about
FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic RetinopathyNADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina.The retinal renin-angiotensin system: roles of angiotensin II and aldosterone.Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system.Foxp3+ Tregs are recruited to the retina to repair pathological angiogenesis.The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies.The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death.Endothelin-2 injures the blood-retinal barrier and macroglial Müller cells:: interactions with angiotensin II, aldosterone, and NADPH oxidase.A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy.Ebselen by modulating oxidative stress improves hypoxia-induced macroglial Müller cell and vascular injury in the retina.Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells.Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.Prorenin stimulates a pro-angiogenic and pro-inflammatory response in retinal endothelial cells and an M1 phenotype in retinal microglia.Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.Neovascularization Is Attenuated With Aldosterone Synthase Inhibition in Rats With RetinopathyAliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 ratInhibition of the Nuclear Receptor RORγ and Interleukin-17A Suppresses Neovascular RetinopathyHighlightsIntravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists attenuates hypertensive and diabetic retinopathy in ratsNox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in RetinopathyLimiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory DemyelinationAngiotensin II and aldosterone activate retinal microgliaAngiotensin II and aldosterone in retinal vasculopathy and inflammation
P50
Q28546854-6A2BEEA5-FF2A-49F6-B1D5-92172BED3D8FQ33632781-3704D1C7-FE01-4BC6-AA47-0B44DF24DB58Q34487307-E1F627C8-0ADF-4C28-AF12-F3DF392EA874Q38005863-A78E30DE-340F-4296-8AF2-A1A63EDF3230Q38100285-1685E1A0-E857-4035-9D0F-CD492DD42260Q42185319-FD662901-D741-4CE7-ABEE-C1517F3FFB98Q42370368-A91FCFAC-45F9-49B2-B505-35AFACC0C3F6Q46193158-81BD0F5C-A756-4701-863B-188DED0ADB82Q46238273-8B41C50E-37C4-4018-AEB2-EF59DE973F99Q46575262-9FCDE25F-AABD-40B6-851C-F4C1D3176612Q46737516-2FD9199C-A05A-47DC-9A70-8313A22B14CDQ47129278-FA2773A2-22CF-46A4-86F6-2F08694B32C6Q48185410-C6BF89D1-3713-4499-9B66-65CFC86AC649Q50146816-4FA3E87C-BAFA-4057-9F5E-379732711A02Q52939927-32BF3DED-FF7E-470D-981D-384DA66DEB2CQ54288745-D743C54D-F5FB-40A6-AC0E-A3A4C27362C0Q54338867-7770718F-E8EF-43DE-BE03-85997307DB40Q60169515-BBB8055D-ACAD-4AE2-9FC3-400BE6BE159CQ60169516-0B3D0E6C-2B74-4A8F-BB2D-BB33DD23A879Q60169526-F80BBCF0-8244-42D6-B3DB-1A5EB34DAB90Q89259797-8A64FF73-DC1C-4FE6-B159-AF0A243015B7Q89958563-92645E3E-FBB9-49C2-9268-9E0003DC2D73Q91802977-2C57563D-8D7F-451F-9A6F-97B518659D30Q92297961-CB59B536-5202-4885-9B8C-988077B2521DQ92698628-DD0F6CB8-C0FB-4DFE-A789-81B341F00379
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Devy Deliyanti
@ast
Devy Deliyanti
@en
Devy Deliyanti
@es
Devy Deliyanti
@nl
type
label
Devy Deliyanti
@ast
Devy Deliyanti
@en
Devy Deliyanti
@es
Devy Deliyanti
@nl
prefLabel
Devy Deliyanti
@ast
Devy Deliyanti
@en
Devy Deliyanti
@es
Devy Deliyanti
@nl
P106
P31
P496
0000-0002-0390-3454